Treatment for atopic dermatitis has changed dramatically, with new therapies offering more targeted relief across the severity spectrum. This course highlights recent drug approvals, updated guideline recommendations, and the clinical implications of managing atopic dermatitis as a chronic inflammatory condition. You will learn how pharmacists can guide therapy decisions, enhance adherence, and improve patient outcomes in personalized atopic dermatitis care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

Melanie Plotke, PharmD
Manager, Clinical Research
American Academy of Dermatology

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence. 

Pharmacist CE Subscription: All your CE in one convenient subscription.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!

The Pharmacist CE Subscription includes: 
-  Compliance and licensure CE 
-  GameChangers Clinical Updates
-  Practical continuing education across patient care topics 

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. 

Purchase Now!

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

 
CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase the Pharmacist CE Subscription and claim your CPE credit, click here or to purchase this course individually, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the updated treatment landscape for atopic dermatitis, including new topical and systemic options.
2. Identify opportunities for pharmacists to collaborate and support atopic dermatitis management through therapy recommendations, patient education, and adherence strategies.

Rachel Maynard and Melanie Plotke have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-074-H01-P
Initial release date: 4/16/2026
Expiration date: 4/16/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram